Article Sidebar

PDF
Date Published: 19/02/2023
Abstract Views: 331
Views PDF: 125
DOI: https://doi.org/10.51298/vmj.v522i2.4302
Issue
Vol. 522 No. 2 (2023)
Section
Các bài báo
How to Cite
Nguyễn, L. M. T., Ngô , M. H., & Nguyễn, Đức Đông. (2023). EC-IC BYPASS SURGERY FOR TREATMENT OF MOYAMOYA DISEASE. Vietnam Medical Journal, 522(2). https://doi.org/10.51298/vmj.v522i2.4302

EC-IC BYPASS SURGERY FOR TREATMENT OF MOYAMOYA DISEASE

Lê Minh Tiến Nguyễn1,, Mạnh Hùng Ngô 2, Đức Đông Nguyễn2
1 Hanoi medical university
2 Viet Duc hospital

Main Article Content

Abstract

Objective: Assessment for result of the Extracranial-to-Intracranial bypass surgery for treatment of Moyamoya disease/ syndrome. Methods: A retrospective and prospective descriptive study on 23 patients with MMD and MMS treated 25 Extracranial-to-Intracranial bypass surgeries performed from January 2017 to June 2022 at the Neurosurgery Center, Viet Duc Hospital. Results: There are 23 patients with an average age of 29.4 years (range from 06 to 63 years) using Extracranial-to-Intracranial Bypass procedures (Direct, Indirect, and Combined). The patient's clinical symptoms and signs (headache, neurological deficits, and TIA) have improved. There were no deaths following surgery, but there was one case of skin flap necrosis and two cases of delayed wound healing, one case chronic subdural hematoma. Conclusion: In patients with MMD, EC-IC bypass surgery is low risk, effective therapy in preventing future ischemic events and strokes, improves the quality of life. Patients with symptomatic MMD should be offered EC-IC bypass surgery.

Article Details

Keywords

Moyamoya, arterial bypass, ischemic stroke, intracranial hemorrhage

References

1. Trần Minh Trí. Phẫu thuật bắc cầu động mạch não điều trị bệnh moyamoya. Tạp Chí Học Thực Hành. 779+780:499-505.
2. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226-1237. doi:10.1056/NEJMra0804622
3. Nah HW, Kwon SU, Kang DW, Ahn JS, Kwun BD, Kim JS. Moyamoya disease-related versus primary intracerebral hemorrhage: [corrected] location and outcomes are different. Stroke. 2012;43(7):1947-1950. doi:10.1161/STROKEAHA.112.654004
4. Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR. Moyamoya disease: a summary. Neurosurg Focus. 2009;26(4):E11. doi:10.3171/2009.1.FOCUS08310
5. Direct, Indirect, and Combined Extracranial-to-Intracranial Bypass for Adult Moyamoya Disease: An Updated Systematic Review and Meta-Analysis | Stroke. Accessed October 14, 2022. https://www.ahajournals.org/ doi/10.1161/STROKEAHA.122.039584
6. Sundaram S, Sylaja PN, Menon G, et al. Moyamoya disease: a comparison of long term outcome of conservative and surgical treatment in India. J Neurol Sci. 2014;336(1-2):99-102. doi:10.1016/j.jns.2013.10.014
7. Acker G, Schlinkmann N, Fekonja L, et al. Wound healing complications after revascularization for moyamoya vasculopathy with reference to different skin incisions. Neurosurg Focus. 2019;46(2):E12. doi:10.3171/ 2018.11.FOCUS18512
8. Kanamori F, Araki Y, Yokoyama K, et al. Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease. Acta Neurochir (Wien). 2021; 163(5):1485-1491. doi:10.1007/s00701-020-04668-0